India, April 15 -- Clearmind Medicine Inc. (CMND) announced that its independent Data and Safety Monitoring Board has issued a positive recommendation to continue the ongoing FDA-approved Phase I/IIa ... Read More
Mumbai, April 15 -- If you're planning to invest in NA plots, luxury villas, farmhouses, or second homes , the Land & Leisure Homes Expo 2026 (LLHE) is the must-attend real estate e... Read More
Mumbai, April 15 -- Alfa Transformers has cancelled the board meeting which was scheduled to be held on 15 April 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More
India, April 15 -- A report released by the Federal Reserve Bank of New York on Wednesday unexpectedly showed a moderate increase in New York manufacturing activity in the month of April. The New Yor... Read More
India, April 15 -- Morgan Stanley (MS) shares climbed 4.22 percent to $191.07, gaining $7.73 on Wednesday, after the company reported strong first-quarter results driven by robust revenue growth and l... Read More
India, April 15 -- Shares of ASML Holding N.V. (ASML) slipped nearly 4% on Wednesday morning after reporting first-quarter results, despite both profit and revenues rising from last year. The stock i... Read More
Mumbai, April 15 -- Sanghvi Movers announced that Saumil Dave has been appointed as the Chief Operating Officer (COO) of the Company and designated as Senior Management Personnel. Published by HT Dig... Read More
Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 15 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More